<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: financial ties</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Aspirin still first-line therapy for unstable angina/NSTEMI</title>
   	 <description>(HealthDay) -- Aspirin is still the first line of therapy for patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and ticagrelor can be used in place of clopidogrel or prasugrel instead of aspirin or as a second antiplatelet agent, according to a report from the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) published online July 16 in Circulation.</description>
     <link>http://medicalxpress.com/news/2012-07-aspirin-first-line-therapy-unstable-anginanstemi.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 17 Jul 2012 03:31:44 EST</pubDate>
	 <guid isPermaLink="false">news261714695</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/aspirinstill.jpg" width="90" height="90" />
</item>
<item>
     <title>Supplement mixture improves memory in mild Alzheimer's</title>
   	 <description>(HealthDay) -- A supplement mixture (Souvenaid) containing dietary precursors and specific nutrients can improve memory in drug-naive patients with mild Alzheimer's disease (AD), according to a study published in the July issue of the Journal of Alzheimer's Disease.</description>
     <link>http://medicalxpress.com/news/2012-07-supplement-mixture-memory-mild-alzheimer.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Thu, 12 Jul 2012 05:50:02 EST</pubDate>
	 <guid isPermaLink="false">news261287299</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/supplementmi.jpg" width="90" height="90" />
</item>
<item>
     <title>Nonnutritive sweetener role in cutting sugar intake explored</title>
   	 <description>(HealthDay) -- Although the evidence is limited, nonnutritive sweeteners (NNS) have a potential role to play in facilitating reduction of added sugar intake, as long as they do not cause a compensatory increase in energy intake, according to a new scientific statement issued by the American Heart Association and the American Diabetes Association and published online July 9 in Circulation.</description>
     <link>http://medicalxpress.com/news/2012-07-nonnutritive-sweetener-role-sugar-intake.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 10 Jul 2012 09:00:01 EST</pubDate>
	 <guid isPermaLink="false">news261127965</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/nonnutritive.jpg" width="90" height="90" />
</item>
<item>
     <title>Hep B screening urged before TNF-alpha inhibitor therapy</title>
   	 <description>(HealthDay) -- All patients with psoriasis should be screened for hepatitis B surface antigen and hepatitis B core antibody prior to the initiation of tumor necrosis factor-alpha inhibitor therapy, according to research published online June 25 in the Journal of the American Academy of Dermatology.</description>
     <link>http://medicalxpress.com/news/2012-07-hep-screening-urged-tnf-alpha-inhibitor.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 01 Jul 2012 13:51:13 EST</pubDate>
	 <guid isPermaLink="false">news260369467</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/hepbscreenin.jpg" width="90" height="90" />
</item>
<item>
     <title>Specific solvents may increase risk of Parkinson's disease</title>
   	 <description>(HealthDay) -- Exposure to specific solvents is associated with an increased risk of Parkinson's disease, according to a study published in the June issue of the Annals of Neurology.</description>
     <link>http://medicalxpress.com/news/2012-06-specific-solvents-parkinson-disease.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Wed, 27 Jun 2012 18:50:01 EST</pubDate>
	 <guid isPermaLink="false">news260040179</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/specificsolv.jpg" width="90" height="90" />
</item>
<item>
     <title>Obese asthma patients have reduced treatment response</title>
   	 <description>(HealthDay) -- Compared with lean patients, obese patients with asthma have higher neutrophil counts and a reduced response to corticosteroid treatment, according to a study published online June 12 in Allergy.</description>
     <link>http://medicalxpress.com/news/2012-06-obese-asthma-patients-treatment-response.html</link>
	 <category>Overweight and Obesity</category>
	 <pubDate>Mon, 25 Jun 2012 15:10:01 EST</pubDate>
	 <guid isPermaLink="false">news259853979</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/obeseasthmap.jpg" width="90" height="90" />
</item>
<item>
     <title>No therapy for 20 percent with stage IV solid tumors</title>
   	 <description>(HealthDay) -- About 20 percent of patients diagnosed with stage IV metastatic solid tumors do not receive anticancer treatment, according to a study published online June 15 in Cancer.</description>
     <link>http://medicalxpress.com/news/2012-06-therapy-percent-stage-iv-solid.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 23 Jun 2012 06:58:31 EST</pubDate>
	 <guid isPermaLink="false">news259653498</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/notherapyfor.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists explain how they created bird flu that spreads easily among mammals</title>
   	 <description>Scientists have created versions of the H5N1 bird flu that spread easily among mammals through droplets in sneezes and have concluded that the deadly virus could trigger a global pandemic in humans.</description>
     <link>http://medicalxpress.com/news/2012-06-pandemic-bird-flu-transmissible-air.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 22 Jun 2012 14:30:08 EST</pubDate>
	 <guid isPermaLink="false">news259594201</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/pandemicbird.jpg" width="90" height="90" />
</item>
<item>
     <title>Many psoriasis patients undertreated for CV risk factors</title>
   	 <description>(HealthDay) -- A large proportion of patients with moderate-to-severe plaque psoriasis are underdiagnosed and undertreated for cardiovascular (CV) risk factors, according to a study published in the July issue of the Journal of the American Academy of Dermatology.</description>
     <link>http://medicalxpress.com/news/2012-06-psoriasis-patients-undertreated-cv-factors.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 22 Jun 2012 10:40:01 EST</pubDate>
	 <guid isPermaLink="false">news259577534</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/manypsoriasi.jpg" width="90" height="90" />
</item>
<item>
     <title>Mental imagery doesn't improve surgeon performance</title>
   	 <description>(HealthDay) -- Mental imagery (MI) training does not result in an improvement in objective surgical assessment of novice gynecological surgeons performing vaginal hysterectomies (VHs), but does correlate with improvements in resident self-confidence, according to a study published online June 7 in BJOG: An International Journal of Obstetrics and Gynaecology.</description>
     <link>http://medicalxpress.com/news/2012-06-mental-imagery-doesnt-surgeon.html</link>
	 <category>Obstetrics &amp; gynaecology</category>
	 <pubDate>Mon, 18 Jun 2012 13:03:40 EST</pubDate>
	 <guid isPermaLink="false">news259243406</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/mentalimager.jpg" width="90" height="90" />
</item>
<item>
     <title>Weight loss linked to reduced cancer incidence, mortality</title>
   	 <description>(HealthDay) -- Weight loss, particularly intentional weight loss, is associated with a reduced incidence of cancer and mortality, especially for women and for obesity-related cancers, according to a review published online June 4 in Obesity Reviews.</description>
     <link>http://medicalxpress.com/news/2012-06-weight-loss-linked-cancer-incidence.html</link>
	 <category>Overweight and Obesity</category>
	 <pubDate>Fri, 15 Jun 2012 15:00:01 EST</pubDate>
	 <guid isPermaLink="false">news258983773</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/weightlossli.jpg" width="90" height="90" />
</item>
<item>
     <title>Psoriasis tied to 14 other autoimmune diseases</title>
   	 <description>(HealthDay) -- Patients with psoriasis have significantly higher odds for having at least one of 14 other autoimmune diseases, according to a study published online June 4 in the Journal of the American Academy of Dermatology.</description>
     <link>http://medicalxpress.com/news/2012-06-psoriasis-tied-autoimmune-diseases.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 15 Jun 2012 14:30:01 EST</pubDate>
	 <guid isPermaLink="false">news258983810</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/psoriasistie.jpg" width="90" height="90" />
</item>
<item>
     <title>Link between vascular disease and disc height loss examined</title>
   	 <description>(HealthDay) -- The association between vascular disease, as measured by abdominal aortic calcifications (AACs), and disc height loss is independent of cardiovascular disease and is largely explained by patient age, gender, and body mass index (BMI), according to a study published in the April issue of The Spine Journal.</description>
     <link>http://medicalxpress.com/news/2012-06-link-vascular-disease-disc-height.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 08 Jun 2012 13:20:02 EST</pubDate>
	 <guid isPermaLink="false">news258376752</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/linkbetweenv.jpg" width="90" height="90" />
</item>
<item>
     <title>Higher risk of VTE in CKD surgical patients on enoxaparin</title>
   	 <description>(HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin compared to those treated with desirudin, according to a study published online June 4 in the Journal of Thrombosis and Haemostasis.</description>
     <link>http://medicalxpress.com/news/2012-06-higher-vte-ckd-surgical-patients.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 08 Jun 2012 12:30:01 EST</pubDate>
	 <guid isPermaLink="false">news258376565</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/higherriskof.jpg" width="90" height="90" />
</item>
<item>
     <title>Many patients keep using PPIs after negative GERD test</title>
   	 <description>(HealthDay) -- Nearly half of patients continue to use proton pump inhibitors (PPIs) even after pH studies confirm that they do not have gastroesophageal reflux disease (GERD), and most do not recall being instructed to stop taking PPIs, according to a study published in the June issue of Clinical Gastroenterology and Hepatology.</description>
     <link>http://medicalxpress.com/news/2012-06-patients-ppis-negative-gerd.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 05 Jun 2012 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news258120463</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/manypatients.jpg" width="90" height="90" />
</item>
<item>
     <title>ASCO: Continuing avastin with 2nd-line chemo ups survival</title>
   	 <description>(HealthDay) -- Continuing use of bevacizumab (Avastin) in combination with second-line chemotherapy improves overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC) who have progressed after discontinuation of first-line bevacizumab and chemotherapy, according to the results of a phase III study presented at the annual meeting of the American Society of Clinical Oncology, held from June 1 to 5 in Chicago.</description>
     <link>http://medicalxpress.com/news/2012-06-asco-avastin-2nd-line-chemo-ups.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 05 Jun 2012 13:30:01 EST</pubDate>
	 <guid isPermaLink="false">news258120168</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ascocontinui.jpg" width="90" height="90" />
</item>
<item>
     <title>Head lice beginning to show permethrin resistance</title>
   	 <description>(HealthDay) -- Although live head lice obtained from school-aged children in Paris remain susceptible to the insecticide malathion, approximately 14 percent have been found to be resistant to permethrin, suggesting a strong basis for future insecticide resistance, according to research published online May 24 in the Journal of the American Academy of Dermatology.</description>
     <link>http://medicalxpress.com/news/2012-06-lice-permethrin-resistance.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 05 Jun 2012 13:01:07 EST</pubDate>
	 <guid isPermaLink="false">news258120033</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/headlicebegi.jpg" width="90" height="90" />
</item>
<item>
     <title>ASCO: Trametinib improves survival in metastatic melanoma</title>
   	 <description>(HealthDay) -- For patients with metastatic melanoma with activating mutations in serine-threonine protein kinase B-RAF (BRAF), treatment with the oral selective MEK inhibitor trametinib is associated with improved progression-free and overall survival, compared with chemotherapy, according to a study published online June 4 in the New England Journal of Medicine to coincide with presentation at the annual meeting of the American Society of Clinical Oncology, held from June 1 to 5 in Chicago.</description>
     <link>http://medicalxpress.com/news/2012-06-asco-trametinib-survival-metastatic-melanoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 05 Jun 2012 04:10:01 EST</pubDate>
	 <guid isPermaLink="false">news258086357</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ascotrametin.jpg" width="90" height="90" />
</item>
<item>
     <title>Statewide coordinated STEMI approach deemed successful</title>
   	 <description>(HealthDay) -- A statewide coordinated effort across hospitals and emergency medical service (EMS) providers to transport patients with ST-segment elevation myocardial infarction (STEMI) to hospitals providing percutaneous coronary intervention (PCI) has resulted in improved outcomes, according to a study published online June 4 in Circulation.</description>
     <link>http://medicalxpress.com/news/2012-06-statewide-stemi-approach-deemed-successful.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 05 Jun 2012 03:38:13 EST</pubDate>
	 <guid isPermaLink="false">news258086277</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/statewidecoo.jpg" width="90" height="90" />
</item>
<item>
     <title>Acellular dermal matrix safe, useful in breast reconstruction</title>
   	 <description>(HealthDay) -- Acellular dermal matrices provide good outcomes for patients undergoing breast reconstruction following mastectomy, but the human AlloDerm matrix has a higher seroma rate than porcine Strattice matrix, according to a study published in the June issue of Plastic and Reconstructive Surgery.</description>
     <link>http://medicalxpress.com/news/2012-06-acellular-dermal-matrix-safe-breast.html</link>
	 <category>Surgery</category>
	 <pubDate>Sat, 02 Jun 2012 05:30:01 EST</pubDate>
	 <guid isPermaLink="false">news257829880</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/acellularder.jpg" width="90" height="90" />
</item>
<item>
     <title>Spondylolisthesis linked to spinous process fractures</title>
   	 <description>(HealthDay) -- There is a strong association between degenerative spondylolisthesis and spinous process fracture in patients undergoing interspinous process spacer (IPS) surgery, according to a study published online May 24 in The Spine Journal.</description>
     <link>http://medicalxpress.com/news/2012-06-spondylolisthesis-linked-spinous-fractures.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sat, 02 Jun 2012 04:50:01 EST</pubDate>
	 <guid isPermaLink="false">news257829849</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/spondylolist.jpg" width="90" height="90" />
</item>
<item>
     <title>More bone grafts, screws tied to less spinal reconstruction stress</title>
   	 <description>(HealthDay) -- Increasing the number of bone grafts and screws used for fusing multiple cervical spine segments yields a more stable construct that decreases the stresses at the graft end plate and bone-screw interfaces, according to a study published online May 10 in The Spine Journal.</description>
     <link>http://medicalxpress.com/news/2012-06-bone-grafts-tied-spinal-reconstruction.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 01 Jun 2012 04:38:34 EST</pubDate>
	 <guid isPermaLink="false">news257744286</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/morebonegraf.jpg" width="90" height="90" />
</item>
<item>
     <title>Epidemiology of rosacea described in United Kingdom</title>
   	 <description>(HealthDay) -- The incidence of rosacea in the United Kingdom is 1.65 per 1,000 person-years, with alcohol consumption linked to a modest increase in risk and current smoking linked to an decreased risk, according to a study published online May 5 in the British Journal of Dermatology.</description>
     <link>http://medicalxpress.com/news/2012-05-epidemiology-rosacea-kingdom.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 21 May 2012 04:40:01 EST</pubDate>
	 <guid isPermaLink="false">news256791790</guid>
	 
</item>
<item>
     <title>ASCO: Dabrafenib/Trametinib active in metastatic melanoma</title>
   	 <description>(HealthDay) -- For patients with V600 BRAF-mutant solid tumors, treatment with the oral BRAF inhibitor dabrafenib and the oral MEK 1/2 inhibitor trametinib is tolerated and has clinical activity in BRAF inhibitor-naive metastatic melanoma, according to a study released May 16 in advance of presentation at the annual meeting of the American Society of Clinical Oncology, held from June 1 to 5 in Chicago.</description>
     <link>http://medicalxpress.com/news/2012-05-asco-dabrafenibtrametinib-metastatic-melanoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 17 May 2012 13:52:34 EST</pubDate>
	 <guid isPermaLink="false">news256480626</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ascodabrafen.jpg" width="90" height="90" />
</item>
<item>
     <title>Leukoencephalopathy risk factors ID'd for MS drug</title>
   	 <description>(HealthDay) -- Drug company researchers say they've determined which multiple sclerosis patients are most vulnerable to developing a rare brain infection while taking a powerful drug called Tysabri (natalizumab).</description>
     <link>http://medicalxpress.com/news/2012-05-leukoencephalopathy-factors-idd-ms-drug.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 17 May 2012 05:30:01 EST</pubDate>
	 <guid isPermaLink="false">news256450373</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/leukoencepha.jpg" width="90" height="90" />
</item>
<item>
     <title>Peptide level ups diagnosis of heart failure in primary care</title>
   	 <description>(HealthDay) -- For patients presenting with dyspnea, the additional measurement of B-type natriuretic peptide (BNP) levels increases the certainty of diagnosis of heart failure and accelerates initiation of appropriate treatment, but does not reduce medical costs, according to a study published online May 2 in the Journal of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2012-05-peptide-ups-diagnosis-heart-failure.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 15 May 2012 13:55:11 EST</pubDate>
	 <guid isPermaLink="false">news256308905</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/peptidelevel.jpg" width="90" height="90" />
</item>
<item>
     <title>Sumatriptan/Naproxen helpful in treating teens' migraines</title>
   	 <description>(HealthDay) -- Treatment with sumatriptan and naproxen sodium (suma/nap) is well tolerated and effective in reducing migraine pain in adolescents, according to a study published online May 14 in Pediatrics.</description>
     <link>http://medicalxpress.com/news/2012-05-sumatriptannaproxen-teens-migraines.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 15 May 2012 04:46:07 EST</pubDate>
	 <guid isPermaLink="false">news256275961</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/sumatriptann.jpg" width="90" height="90" />
</item>
<item>
     <title>Health-related QoL evaluated for children with brain tumors</title>
   	 <description>(HealthDay) -- In children and adolescents with brain tumors treated with proton radiation, health-related quality of life (HRQoL) scores are affected by both disease type and treatment, with assessments made by the patients correlating well with those of their parents, according to a study published online May 7 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-05-health-related-qol-children-brain-tumors.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 09 May 2012 12:58:52 EST</pubDate>
	 <guid isPermaLink="false">news255787046</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/healthrelate.jpg" width="90" height="90" />
</item>
<item>
     <title>No benefit of induction chemo, high-dose boost in anal cancer</title>
   	 <description>(HealthDay) -- Neither induction chemotherapy (ICT) nor high-dose radiation boost is associated with an improvement in five-year colostomy-free survival (CFS) in patients with locally advanced anal canal carcinoma (LAACC), according to a study published online April 23 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-04-benefit-induction-chemo-high-dose-boost.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 26 Apr 2012 12:40:01 EST</pubDate>
	 <guid isPermaLink="false">news254659064</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/nobenefitofi.jpg" width="90" height="90" />
</item>
<item>
     <title>Disclosure of financial conflicts of interest may worsen medical bias</title>
   	 <description>&quot;Journals, professional associations, clinical guideline developers, and others need to worry not just that disclosure provides a band-aid to the real problem of the [conflict of interest] itself, but that any attempt to stem the trouble through disclosure policies may actually be worsening the problem,&quot; say the editors of PLoS Medicine writing in an editorial that discusses the response to a paper published in the Journal last month, which examined the financial conflicts of interest of members of the American Psychiatric Association (APA) responsible for updating the Diagnostic and Statistical Manual of Mental Disorders (DSM).</description>
     <link>http://medicalxpress.com/news/2012-04-disclosure-financial-conflicts-worsen-medical.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 24 Apr 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news254505557</guid>
	 
</item>


</channel>
</rss>
